Your browser doesn't support javascript.
loading
Novel Junction-specific and Quantifiable In Situ Detection of AR-V7 and its Clinical Correlates in Metastatic Castration-resistant Prostate Cancer.
Zhu, Yezi; Sharp, Adam; Anderson, Courtney M; Silberstein, John L; Taylor, Maritza; Lu, Changxue; Zhao, Pei; De Marzo, Angelo M; Antonarakis, Emmanuel S; Wang, Mindy; Wu, Xingyong; Luo, Yuling; Su, Nan; Nava Rodrigues, Daniel; Figueiredo, Ines; Welti, Jonathan; Park, Emily; Ma, Xiao-Jun; Coleman, Ilsa; Morrissey, Colm; Plymate, Stephen R; Nelson, Peter S; de Bono, Johann S; Luo, Jun.
Afiliação
  • Zhu Y; Department of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Sharp A; The Institute for Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London, UK.
  • Anderson CM; Advanced Cell Diagnostics, Newark, CA, USA.
  • Silberstein JL; Department of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Taylor M; Department of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Lu C; Department of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Zhao P; Department of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • De Marzo AM; Department of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Oncology, Johns Hopkins University School of Medicine, Baltim
  • Antonarakis ES; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Wang M; Advanced Cell Diagnostics, Newark, CA, USA.
  • Wu X; Advanced Cell Diagnostics, Newark, CA, USA.
  • Luo Y; Advanced Cell Diagnostics, Newark, CA, USA.
  • Su N; Advanced Cell Diagnostics, Newark, CA, USA.
  • Nava Rodrigues D; The Institute for Cancer Research, London, UK.
  • Figueiredo I; The Institute for Cancer Research, London, UK.
  • Welti J; The Institute for Cancer Research, London, UK.
  • Park E; Advanced Cell Diagnostics, Newark, CA, USA.
  • Ma XJ; Advanced Cell Diagnostics, Newark, CA, USA.
  • Coleman I; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Morrissey C; University of Washington, Seattle, WA, USA.
  • Plymate SR; University of Washington, Seattle, WA, USA.
  • Nelson PS; Fred Hutchinson Cancer Research Center, Seattle, WA, USA; University of Washington, Seattle, WA, USA.
  • de Bono JS; The Institute for Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, London, UK. Electronic address: johann.de-bono@icr.ac.uk.
  • Luo J; Department of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: jluo1@jhmi.edu.
Eur Urol ; 73(5): 727-735, 2018 05.
Article em En | MEDLINE | ID: mdl-28866255

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores Androgênicos / Isoformas de Proteínas / Neoplasias de Próstata Resistentes à Castração / Antagonistas de Androgênios Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: Eur Urol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores Androgênicos / Isoformas de Proteínas / Neoplasias de Próstata Resistentes à Castração / Antagonistas de Androgênios Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: Eur Urol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos